Abstract
Expression of inducible nitric oxide synthase (iNOS) and its cellular localization was investigated in subcutaneous or lymph node metastases of human melanoma. Immunohistochemistry revealed that iNOS expression was limited to melanoma cells. In samples of patients without distant metastases, the number of iNOS+ tumour cells/total tumour cells was 55% ± 17% (n = 12) compared with 9% ± 8% when distant metastases of lung, liver or brain occurred within an observation period of 3 years (n = 10) (P < 0.001). Western blotting confirmed the expression of iNOS protein in select cases. Notably, iNOS is expressed in regional melanoma metastases and its expression is inversely related to the tumour's metastatic potential. Thus, iNOS expression may have predictive value for the development of distant metastases of human melanoma. © 1999 Cancer Research Campaign
Keywords: nitric oxide, human melanoma, metastasis
Full Text
The Full Text of this article is available as a PDF (367.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dong Z., Staroselsky A. H., Qi X., Xie K., Fidler I. J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 1994 Feb 1;54(3):789–793. [PubMed] [Google Scholar]
- Messmer U. K., Ankarcrona M., Nicotera P., Brüne B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 1994 Nov 21;355(1):23–26. doi: 10.1016/0014-5793(94)01161-3. [DOI] [PubMed] [Google Scholar]
- Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
- Nathan C., Xie Q. W. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 May 13;269(19):13725–13728. [PubMed] [Google Scholar]
- Pammer J., Plettenberg A., Weninger W., Diller B., Mildner M., Uthman A., Issing W., Stürzl M., Tschachler E. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol. 1996 May;148(5):1387–1396. [PMC free article] [PubMed] [Google Scholar]
- Schmidt H. H., Walter U. NO at work. Cell. 1994 Sep 23;78(6):919–925. doi: 10.1016/0092-8674(94)90267-4. [DOI] [PubMed] [Google Scholar]
- Thomsen L. L., Lawton F. G., Knowles R. G., Beesley J. E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994 Mar 1;54(5):1352–1354. [PubMed] [Google Scholar]
- Thomsen L. L., Miles D. W., Happerfield L., Bobrow L. G., Knowles R. G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer. 1995 Jul;72(1):41–44. doi: 10.1038/bjc.1995.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tschugguel W., Knogler W., Czerwenka K., Mildner M., Weninger W., Zeillinger R., Huber J. C. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer. 1996 Nov;74(9):1423–1426. doi: 10.1038/bjc.1996.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie K., Dong Z., Fidler I. J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol. 1996 Jun;59(6):797–803. doi: 10.1002/jlb.59.6.797. [DOI] [PubMed] [Google Scholar]
- Xie K., Huang S., Dong Z., Juang S. H., Gutman M., Xie Q. W., Nathan C., Fidler I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med. 1995 Apr 1;181(4):1333–1343. doi: 10.1084/jem.181.4.1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie K., Wang Y., Huang S., Xu L., Bielenberg D., Salas T., McConkey D. J., Jiang W., Fidler I. J. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene. 1997 Aug 14;15(7):771–779. doi: 10.1038/sj.onc.1201239. [DOI] [PubMed] [Google Scholar]